1375P Intermediate clinical endpoints (ICE) as potential surrogates for overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 33; p. S1171
Main Authors Halabi, S., Roy, A., Rydzewska, L., Godolphin, P., Parmar, M.K., Hussain, M., Tangen, C., Thompson, I.M., Xie, W., Carducci, M.A., Smith, M., Morris, M.J., Gravis Mescam, G., Dearnaley, D., Verhagen, P., Goto, T., James, N.D., Buyse, M.E., Tierney, J., Sweeney, C.J.
Format Journal Article
LanguageEnglish
Published 01.09.2022
Online AccessGet full text
ISSN0923-7534
DOI10.1016/j.annonc.2022.07.1507

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2022.07.1507